Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-887-6 | CAS number: 75-63-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 977
- Report date:
- 1977
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- yes
- Remarks:
- Only three strains used and three concentrations of the test material tested. No pre-incubation method used and only one positive control used (for strain 1538 with metabolic activation system).
- GLP compliance:
- not specified
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Bromotrifluoromethane
- EC Number:
- 200-887-6
- EC Name:
- Bromotrifluoromethane
- Cas Number:
- 75-63-8
- Molecular formula:
- CBrF3
- IUPAC Name:
- bromotrifluoromethane
- Test material form:
- gas under pressure: liquefied gas
- Details on test material:
- - Name of test material (as cited in study report): PYROFORANE 1301
- Lot/batch No.: 531942Y
Constituent 1
Method
- Target gene:
- his
Species / strain
- Species / strain / cell type:
- other: S. thyphimurium TA 1535, TA 1537 and TA 1538
- Metabolic activation:
- with and without
- Metabolic activation system:
- liver S9-mix prepared from Aroclor 1254-induced Anglia Laboratory rats
- Test concentrations with justification for top dose:
- 10, 30 and 50% (v/v) in air
- Vehicle / solvent:
- air
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 2-acetylaminofluorene
- Remarks:
- only for strain 1538 with metabolic activation system
- Details on test system and experimental conditions:
- The strains were obtained from Professor B. N. Ames, Biochemistry Dept., University of California, Berkeley, California, U.S.A. Sub-cultures were prepared in nutrient broth (Difco) and incubated at 37°C for 18 hours. This overnight culture provides approximately 2E+9 organisms/mL.
Procedure
Two sets of bottles were prepared for each tester strain and 0.1 mL of one of the standard bacterial suspensions was added to each of the bottles. Into each of one of the duplicate sets of bottles was placed 0.5 mL of the S-9 liver microsome mix (Appendix 1). In the other set the S-9 mix was replaced by 0.5 mL volumes of sterile physiological saline.
2.8 mL volumes of histidine deficient agar, melted and cooled to 45°C were added to each of the bottles, thoroughly mixed and then over layed onto previously prepared plates containing 15 mL of minimal agar. Duplicate sets of plates were used for each concentration of test material.
Pyroforane 1301 was tested as a percentage mixture in compressed air. Three dose-levels were used, 50%, 30% and 10% gas mixture respectively.
To obtain the correct gas mixture two Rotameters were used to measure the gas flow of the test materials and compressed air. The gas was passed to a 100 mL pyrex mixing vessel via silicone rubber tubing and allowed to equilibrate inside the mixing vessel for 2 minutes. After equilibration the gas mixture was passed from the mixing vessel to standard Mc Intosh and Fildes jars which contained the petri dishes seeded with tester strain and, where applicable, the liver microsomal extract. The test gas mixture was applied until the jar was full of the test gas mixture.
The gas flow rates used to provide the required gas mixtures are as indicated below:
- 50% of gas mixture for a flow rate (in cc/min) of 150/150 (Air/Test gas)
- 30% of gas mixture for a flow rate (in cc/min) of 150/72.5 (Air/Test gas)
- 10% of gas mixture for a flow rate (in cc/min) of 135/15 (Air/Test gas)
- Air for a flow rate (in cc/min) of 150/0 (Air/Test gas)
When the gas jars were filled with the test gas mixture, the jars were sealed and placed inside a 37°C incubator for 48 hours. The number of revertant bacterial colonies arising on each plate was counted.
This procedure was repeated for each of the bacterial tester strains on the test gas of Pyroforane 1301.
A further set of plates was prepared without the tester strains to ensure that extraneous contamination had not occurred during the preparation of the materials and test plates.
Finally, serial ten-fold dilutions of the standardised suspensions were prepared and 0.3 mL aliquots of some dilutions were mixed with 2.7 mL volumes of agar and overlayed onto minimal agar plates. The 1E-1 dilutions was mixed with histidine deficient agar to check the spontaneous mutation rate, and the 1E-6 to 1E-8 dilutions were mixed with the histidine rich agar to confirm the viability of the prepared suspensions. - Evaluation criteria:
- After incubation for 48 hours at 37°C the numbers of revertant (histidine independent) colonies were counted and compared with negative controls. The numbers of colonies developing on the first set of plates indicated the degree of reverse mutation caused by the test material itself and the numbers developing on the second set of plates (with rat liver microsomal fraction) indicated the degree of reverse mutation due to metabolites of the test compound.
Results and discussion
Test results
- Species / strain:
- other: S. thyphimurium TA 1535, TA 1537 and TA 1538
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Low colony counts at 1E-1 dilution when cells were plated onto histidine deficient agar indicate that the strain is maintaining its low spontaneous mutation rate. High colony counts at the 1E-6 to 1E-7 dilutions indicate that the viability of the strain is good. The positive control provoked increases in the number of revertant colonies.
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
Bromotrifluoromethane did not show a mutagenic response under the conditions of the test. - Executive summary:
Mutagenic activity of bromotrifluoromethane was evaluated by using 3 histididine dependent strains of Salmonella typhimurium (TA 1535, TA 1537 and TA 1538) . Tests were carried out in presence and in absence of Rat liver derived S-9 mix activation system. Cells were incubated with 10, 30 and 50% (v/v in air) HFC-32 for 48 hours at 37°C. 2 -amino positive controls were used in the presence (2 -aminoanthracene) and in the absence (nitrosoguanidine, acridine, daunorubicine and aminoanthracene) of S-9 mix. No significant cytotoxicity was evidenced and no significant increases in the number of revertant colonies were observed in any experiment, whatever the strain and dose with and without metabolic activation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.